Table 1

Prevalence of the 471delAAAG variant in RNASEL in Ashkenazi Jewish men with prostate cancer and in Ashkenazi Jewish controls

No of carriers (%)
*Fisher's exact test, two sided p value.
Prostate ca diagnosed at <65 years1/38 (2.63)
Prostate ca diagnosed at ≥65 years0/73 (0)
All affected men1/111, (0.90)
    (95% CI)(0.02 to 4.9)
All controls2/105 (1.9)
    (95% CI)(0.23 to 6.7)
Comparison of cases and controlsOdds ratio = 0.47, p=0.61*
    (95% CI)(0.08 to 9.2)